• David B Olawade, Ojima Z Wada, Chiamaka Norah Ezeagu, Nicholas Aderinto, Malik A Balogun, Fiyinfoluwa T Asaolu, and Aanuoluwapo Clement David-Olawade.
• Department of Allied and Public Health, School of Health, Sport and Bioscience, University of East London, London, UK.
• Medicine (Baltimore). 2024 Jun 14; 103 (24): e38565e38565.

AbstractMalaria remains an endemic public health concern in Africa, significantly contributing to morbidity and mortality rates. The inadequacies of traditional prevention measures, like integrated vector management and antimalarial drugs, have spurred efforts to strengthen the development and deployment of malaria vaccines. In addition to existing interventions like insecticide-treated bed nets and artemisinin-based combination therapies, malaria vaccine introduction and implementation in Africa could drastically reduce the disease burden and hasten steps toward malaria elimination. The malaria vaccine rollout is imminent as optimistic results from final clinical trials are anticipated. Thus, determining potential hurdles to malaria vaccine delivery and uptake in malaria-endemic regions of sub-Saharan Africa will enhance decisions and policymakers' preparedness to facilitate efficient and equitable vaccine delivery. A multisectoral approach is recommended to increase funding and resources, active community engagement and participation, and the involvement of healthcare providers.Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.

11 keywords...

hide…